Indosys Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 3.00 M
- Revenue Growth 8.30%
- Profit Growth 22.62%
- Ebitda 30.19%
- Net Worth 59.05%
- Total Assets 16.29%
About Indosys Life Science
Indosys Life Science Private Limited (ILSPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 March 2011 and has a history of 13 years and ten months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Kala Sadashiva and Prateek Kulkarni serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233KA2011PTC057538
-
Company No.
057538
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Mar 2011
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Indosys Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kala Sadashiva
|
Director | 15-Sep-2016 | Current |
|
Prateek Kulkarni
|
Director | 23-Jul-2021 | Current |
Financial Performance of Indosys Life Science.
Indosys Life Science Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 8.3% increase. The company also saw a substantial improvement in profitability, with a 22.62% increase in profit. The company's net worth Soared by an impressive increase of 59.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indosys Life Science?
In 2016, Indosys Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Dec 2017 | Hdfc Bank Limited | ₹3.00 M | Open |
How Many Employees Work at Indosys Life Science?
Unlock and access historical data on people associated with Indosys Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indosys Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indosys Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
